Thursday, April 10, 2025
- Advertisement -spot_img

TAG

weight-loss drugs

Novo Nordisk beats on Wegovy sales, expects slower 2025 growth

Danish drugmaker Novo Nordisk (NVO) reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's expectations and bumping...

PepsiCo CEO: GLP-1 drugs are ‘not impacting us’

PepsiCo (PEP) CEO Ramon Laguarta said GLP-1 drugs for weight loss and diabetes, such as Ozempic, Wegovy, and Mounjaro, aren't yet having an effect...

Latest news

- Advertisement -spot_img